This inventor holds 1 USPTO granted patent and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignee: Ethypharm, Inc.. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Laury Trichard: Innovator in Pharmaceutical Formulations
Introduction
Laury Trichard is a notable inventor based in Pony de l'Arche, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral drug formulations. His innovative approach has led to the creation of a unique pharmaceutical form that addresses specific challenges in drug delivery.
Latest Patents
Laury Trichard holds a patent for an "Alcohol-resistant oral pharmaceutical form." This invention features a sustained release oral pharmaceutical form suitable for single daily dose administration. It includes a neutral microgranule coated with a mounting layer of active ingredient and a pharmaceutically acceptable binder. Additionally, it has a coating layer of a hydrophobic coating polymer derived from a non-water soluble cellulose derivative, with at least 20% of inert load in relation to the dry weight of the hydrophobic coating polymer. This pharmaceutical form demonstrates improved resistance to the rapid release of the active ingredient, particularly in the presence of alcohol. He has 1 patent to his name.
Career Highlights
Laury Trichard is currently associated with Ethypharm, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on enhancing drug formulations to improve patient outcomes and medication adherence.
Collaborations
One of his notable collaborators is Catherine Herry, who contributes her expertise to their joint projects. Together, they work on advancing pharmaceutical technologies that can benefit a wide range of patients.
Conclusion
Laury Trichard's contributions to the pharmaceutical industry exemplify the importance of innovation in drug delivery systems. His work not only addresses critical challenges but also paves the way for future advancements in the field.
